Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nitto Denko Avecia Opens Expanded Mfg. Ops | Contract Pharma

What are you searching for?

Sign in
Breaking News

Nitto Denko Avecia Opens Expanded Mfg. Ops

Adds 20,000 sq.-ft. of manufacturing and office space in Milford, MA

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Nitto Denko Avecia Inc. has opened its new oligonucleotide API manufacturing facility in Milford, MA. The expansion adds 20,000 sq.-ft. of manufacturing and office space at the and provides CGMP oligonucleotide manufacturing capacity up to 1.8mol. The total capacity of Avecia’s Milford site has now more than doubled up to 3.0mol, which makes Avecia in Milford, MA the largest oligonucleotide manufacturing site in the world.

According to Avecia’s president Detlef Rethage, “This expansion will help Avecia’s clients to receive timely oligonucleotide API to advance their drug development programs in clinical trials as planned. “Avecia takes pride that our engineers have introduced novel technology, executed this expansion in record time, and in close collaboration with A/Z Corporation to ensure the timely supply of novel oligonucleotide therapeutics,” said Rethage.

Avecia has added more than 120 jobs in the last 12 months in Milford and currently has more than 50 open positions at its four locations in MA, OH, and CA.  The new positions will specialize in microbiology, analytical chemistry, manufacturing, quality assurance and engineering.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics